MediciNova, Inc.
(NASDAQ:MNOV)
$1.78
-0.03 (-1.66%)
Open: 3:03 PM
MediciNova Stock Price Graph
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- YTD
- All
MediciNova Stock Price Today
MediciNova, Inc. (MNOV) stock declined over -3.26% intraday to trade at $1.78 a share on NASDAQ. The stock opened with a gain of 7.73% at $1.95 and touched an intraday high of $1.95, falling -1.66% against the last close of $1.81. The MediciNova, Inc. in stock market went to a low of $1.92 during the session.
MediciNova Stock Snapshot
$1.81
Prev. Close
87.31 Million
Market Cap
$1.92
Day Low
$1.95
Open
N/A
Number of Shares
$1.95
Day High
N/A
P/E ratio
-0.19
EPS (TTM)
1.05
Cash Flow per Share
N/A
Free Float in %
1.32
Book Value
20632.00
Volume
MediciNova Stock Price History Chart
| Date | Open | High | Low | Close | Volume |
|---|
Contact Details
Company Information
EmployeesN/A
Beta0.86
Sales or Revenue$1 Million
5Y Sales Change-20.00%
Fiscal Year EndsDec. 2022
SectorHealthcare
IndustryBiotechnology
About Company
MediciNova, Inc., a biopharmaceutical company, focuses on developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs in the United States. The company is developing MN-166 (ibudilast), an oral anti-inflammatory and neuroprotective agent for treating neurological disorders, such as primary and secondary progressive multiple sclerosis, amyotrophic lateral sclerosis, chemotherapy-induced peripheral neuropathy, degenerative cervical myelopathy, glioblastoma, and substance dependence and addiction. Its product pipeline also includes MN-221 (bedoradrine), a selective beta-2-adrenergic receptor agonist for the treatment of acute exacerbations of asthma; MN-001 (tipelukast), an orally bioavailable small molecule compound to treat fibrotic diseases, including nonalcoholic steatohepatitis and idiopathic pulmonary fibrosis; and MN-029 (denibulin), a tubulin binding agent for treating solid tumor cancers. The company has collaboration agreements with Kissei Pharmaceutical Co., Ltd.; Kyorin Pharmaceutical Co., Ltd; Angiogene Pharmaceuticals Ltd.; and Meiji Seika Kaisha Ltd. MediciNova, Inc. was incorporated in 2000 and is headquartered in La Jolla, California.
Peers
Frequently Asked Questions
What is the current MediciNova, Inc. (MNOV) stock price?
MediciNova, Inc. (NASDAQ: MNOV) stock price is $1.78 in the last trading session. During the trading session, MNOV stock reached the peak price of $1.95 while $1.92 was the lowest point it dropped to. The percentage change in MNOV stock occurred in the recent session was -3.26% while the dollar amount for the price change in MNOV stock was -$0.06.
MNOV's industry and sector of operation?
The NASDAQ listed MNOV is part of Biotechnology industry that operates in the broader Healthcare sector. MediciNova, Inc. , a biopharmaceutical company, focuses on developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs in the United States.
Who are the executives of MNOV?
Dr. Yuichi Iwaki M.D., Ph.D.
Co-Founder, Pres, Chief Executive Officer & Executive Director
Mr. Jason J. Kruger CPA
Chief Financial Officer & Principal Financial Officer
Dr. Yuichi Iwaki M.D., Ph.D.
Co-Founder, Pres, CEO & Exec. Director
Dr. David H. Crean M.B.A., Ph.D.
Chief Bus. Officer
How MNOV did perform over past 52-week?
MNOV's closing price is 0.12% higher than its 52-week low of $1.89 where as its distance from 52-week high of $2.73 is -0.23%.
How many employees does MNOV have?
Number of MNOV employees currently stands at N/A. MNOV operates from 4275 Executive Square, La Jolla, CA 92037, US.
Link for MNOV official website?
Official Website of MNOV is: https://www.medicinova.com
How do I contact MNOV?
MNOV could be contacted at phone #858 373 1500 and can also be accessed through its website. MNOV operates from 4275 Executive Square, La Jolla, CA 92037, US.
How many shares of MNOV are traded daily?
MNOV stock volume for the day was 20632.00 shares. The average number of MNOV shares traded daily for last 3 months was 97.04 Thousands.
What is the market cap of MNOV currently?
The market value of MNOV currently stands at $87.31 Million with its latest stock price at $1.78 and N/A of its shares outstanding.